ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.177,62
-0,90%
S&P 500
5.469,30
0,39%
Dow Jones
39.112,16
-0,76%
Euro vs US Dollar
1,07115
0,02%
Bitcoin
61.768,21
-0,06%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Targanta Therapeutics Corp (MM) (TARG)

  7. Targanta Therapeutics Corp (MM) (TARG) News

TARG

Targanta Therapeutics Corp (MM) (TARG)

Targanta Therapeutics Corp (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TARG
DatumZeitQuelleÜberschriftSymbolFirma
26/02/200912h06Edgar (US Regulatory)(25-NSE)NASDAQ:TARGTarganta Therapeutics Corp (MM)
25/02/200916h50Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
25/02/200916h05Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
25/02/200916h05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
25/02/200914h30MarketwiredThe Medicines Company Announces Completion of Tender Offer for Shares of Targanta TherapeuticsNASDAQ:TARGTarganta Therapeutics Corp (MM)
20/02/200920h08Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
20/02/200915h59Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
20/02/200913h58Business WireTarganta Enters into Memorandum of Understanding to Resolve Shareholder LawsuitNASDAQ:TARGTarganta Therapeutics Corp (MM)
20/02/200912h01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
17/02/200922h12Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
13/02/200918h03Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
11/02/200923h05Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
11/02/200922h45Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
04/02/200921h28Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
04/02/200912h01Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
27/01/200920h43Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:TARGTarganta Therapeutics Corp (MM)
27/01/200919h08MarketwiredThe Medicines Company Commences Tender Offer for All Outstanding Shares of Targanta TherapeuticsNASDAQ:TARGTarganta Therapeutics Corp (MM)
27/01/200918h54Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:TARGTarganta Therapeutics Corp (MM)
27/01/200912h04Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:TARGTarganta Therapeutics Corp (MM)
27/01/200912h01Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:TARGTarganta Therapeutics Corp (MM)
22/01/200922h49Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:TARGTarganta Therapeutics Corp (MM)
15/01/200922h56Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:TARGTarganta Therapeutics Corp (MM)
14/01/200923h20Edgar (US Regulatory)Current report filing (8-K)NASDAQ:TARGTarganta Therapeutics Corp (MM)
14/01/200921h56Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:TARGTarganta Therapeutics Corp (MM)
14/01/200912h00Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:TARGTarganta Therapeutics Corp (MM)
13/01/200918h13Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:TARGTarganta Therapeutics Corp (MM)
13/01/200904h34MarketwiredThe Medicines Company to Acquire Targanta TherapeuticsNASDAQ:TARGTarganta Therapeutics Corp (MM)
19/12/200822h21Edgar (US Regulatory)Current report filing (8-K)NASDAQ:TARGTarganta Therapeutics Corp (MM)
18/12/200822h05Business WireTarganta Announces Corporate RestructuringNASDAQ:TARGTarganta Therapeutics Corp (MM)
09/12/200812h05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:TARGTarganta Therapeutics Corp (MM)
 Showing the most relevant articles for your search:NASDAQ:TARG

Kürzlich von Ihnen besucht

TG
A3LCXP
Banco Santander
TG
WDL1
Nakiki
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten